Merck KGaA’s EMD Serono strikes MFN deal in Trump's fertility treatment pricing push
17th October 2025 Uncategorised 0Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer its in vitro fertilization (IVF) treatments at a sharp discount on the government’s DTC platform TrumpRx.
More: Merck KGaA’s EMD Serono strikes MFN deal in Trump's fertility treatment pricing push
Source: fierce
